Published in
Nature Research, Nature Medicine, 5(30), p. 1499-1499, 2024
DOI: 10.1038/s41591-024-02898-8
Links
Tools
Author Correction: Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial
Journal article published in 2024 by
Yara L. Verschoor 
,
Joris van de Haar ,
José G. van den Berg,
Johanna W. van Sandick,
Liudmila L. Kodach,
Jolanda M. van Dieren ,
Sara Balduzzi ,
Cecile Grootscholten,
Marieke E. IJsselsteijn,
Alexander A. F. A. Veenhof,
Koen J. Hartemink,
Marieke A. Vollebergh,
Adham Jurdi ,
Shruti Sharma,
Erik Spickard
and other authors.
,
Joris van de Haar ,
José G. van den Berg,
Johanna W. van Sandick,
Liudmila L. Kodach,
Jolanda M. van Dieren ,
Sara Balduzzi ,
Cecile Grootscholten,
Marieke E. IJsselsteijn,
Alexander A. F. A. Veenhof,
Koen J. Hartemink,
Marieke A. Vollebergh,
Adham Jurdi ,
Shruti Sharma,
Erik Spickard
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 